Study to assess the efficacy and safety of Rina-S with or without bevacizumab compared to investigator’s choice of platinum-based chemotherapy with or without bevacizumab as second-line treatment in participants with recurrent platinum- sensitive ovarian cancer

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 91e39584e478fe4d11f83528cc7f825beee1d5e6
First added on: Oct 08, 2026